Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $48.15 and last traded at $48.15, with a volume of 0 shares. The stock had previously closed at $48.15.
Basilea Pharmaceutica Stock Performance
The business has a fifty day simple moving average of $43.71 and a 200 day simple moving average of $41.67.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- 3 Grocery Stocks That Are Proving They Are Still Essential
- GameStop Will Rocket Higher: The Move Won’t Last
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Stocks Insiders are Buying That Should be on Your Radar
- How to Calculate Options Profits
- Momentum Investing: A Guide to Getting Started
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.